257 related articles for article (PubMed ID: 25599612)
41. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
[TBL] [Abstract][Full Text] [Related]
42. Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy.
Miehle K; Ebert T; Kralisch S; Hoffmann A; Kratzsch J; Schlögl H; Stumvoll M; Fasshauer M
Cytokine; 2016 Jul; 83():239-244. PubMed ID: 27179139
[TBL] [Abstract][Full Text] [Related]
43. Insulin resistance and body composition in preterm born children during prepubertal ages.
Darendeliler F; Bas F; Bundak R; Coban A; Sancakli O; Eryilmaz SK; Kucukemre B; Disci R; Gokcay G; Aki S; Ince Z; Eskiyurt N
Clin Endocrinol (Oxf); 2008 May; 68(5):773-9. PubMed ID: 17980003
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
45. GLP-1 and IGF-I levels are elevated in late infancy in low birth weight infants, independently of GLP-1 receptor polymorphisms and neonatal nutrition.
Díaz M; García-Beltran C; López-Bermejo A; de Zegher F; Ibáñez L
Int J Obes (Lond); 2018 Apr; 42(4):915-918. PubMed ID: 29089613
[TBL] [Abstract][Full Text] [Related]
46. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
[TBL] [Abstract][Full Text] [Related]
47. Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age.
Ibáñez L; Lopez-Bermejo A; Díaz M; Suárez L; de Zegher F
J Clin Endocrinol Metab; 2009 Oct; 94(10):3696-9. PubMed ID: 19737922
[TBL] [Abstract][Full Text] [Related]
48. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
[TBL] [Abstract][Full Text] [Related]
49. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
50. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review.
Yuan D; Wu BJ; Henry A; Rye KA; Ong KL
Clin Endocrinol (Oxf); 2019 Jan; 90(1):47-55. PubMed ID: 30346647
[TBL] [Abstract][Full Text] [Related]
51. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
[TBL] [Abstract][Full Text] [Related]
52. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
53. Serum adiponectin concentrations in newborn infants in early postnatal life.
Kamoda T; Saitoh H; Saito M; Sugiura M; Matsui A
Pediatr Res; 2004 Nov; 56(5):690-3. PubMed ID: 15371566
[TBL] [Abstract][Full Text] [Related]
54. Serum glucocorticoids and adiponectin associate with insulin resistance in children born small for gestational age.
Tenhola S; Todorova B; Jääskeläinen J; Jänne OA; Raivio T; Voutilainen R
Eur J Endocrinol; 2010 Mar; 162(3):551-7. PubMed ID: 20019129
[TBL] [Abstract][Full Text] [Related]
55. Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects.
Lips MA; de Groot GH; Berends FJ; Wiezer R; van Wagensveld BA; Swank DJ; Luijten A; van Dijk KW; Pijl H; Jansen PL; Schaap FG
Clin Endocrinol (Oxf); 2014 Dec; 81(6):862-70. PubMed ID: 24841294
[TBL] [Abstract][Full Text] [Related]
56. Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls.
Vienberg SG; Brøns C; Nilsson E; Astrup A; Vaag A; Andersen B
Eur J Endocrinol; 2012 Jul; 167(1):49-57. PubMed ID: 22529197
[TBL] [Abstract][Full Text] [Related]
57. Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth.
Megia A; Gil-Lluis P; Näf S; Ceperuelo-Mallafré V; Gonzalez-Clemente JM; Llauradó G; Nuñez-Roa C; Roche K; Ballesteros M; Yañez RE; Fernández-Veledo S; Vendrell J
Acta Diabetol; 2015 Aug; 52(4):693-700. PubMed ID: 25604041
[TBL] [Abstract][Full Text] [Related]
58. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.
Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Krsek M; Haluzík M
Physiol Res; 2010; 59(3):415-422. PubMed ID: 19681655
[TBL] [Abstract][Full Text] [Related]
59. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity.
Jaquet D; Deghmoun S; Chevenne D; Czernichow P; Lévy-Marchal C
Int J Obes (Lond); 2006 Jan; 30(1):83-7. PubMed ID: 16231036
[TBL] [Abstract][Full Text] [Related]
60. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
